DNA vaccines can be used as targeted therapeutic vaccines to induce an immune response which can detect and destroy infectious diseases and potentially cancer
Genexine to receive an upfront payment and entitled to tiered, single-digit royalties on net sales of HyLeukin plus milestone payments from I-Mab Biopharma (I-Mab).